Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
@article{TLCR38119,
author = {Amulya Yellala and Apar Kishor Ganti},
title = {Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)},
journal = {Translational Lung Cancer Research},
volume = {9},
number = {3},
year = {2020},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/38119}
}